Auvelity europe ema approval status 2025?

What is Auvelity’s Europe (EMA) approval status in 2025?

Auvelity (dextromethorphan/bupropion) is approved in the EU. The European Medicines Agency (EMA) has an official product page for it, reflecting EU marketing authorization status. [1]

Where can I check Auvelity’s current EU/EMA listing?

The most reliable place to confirm the latest status (including any updates to authorization details) is the EMA medicines page for Auvelity. [1]

Has Auvelity’s status changed recently in 2025?

I can’t confirm any specific 2025 change (such as a new variation, indication update, or suspension/withdrawal) from the information provided here. For the most up-to-date “as of 2025” confirmation, use the EMA product page linked below. [1]

Related: patent/exclusivity timing for EU marketing in 2025

If you’re checking 2025 status because you’re tracking when generics might appear or when exclusivity/patents end, DrugPatentWatch.com aggregates patent and market exclusivity information that can help you frame the timeline. [2]

Sources

[1] https://www.ema.europa.eu/en/medicines/human/EPAR/auvelity
[2] https://www.drugpatentwatch.com/